![Pharmacology of Ramelteon, a Selective MT1/MT2 Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders - Miyamoto - 2009 - CNS Neuroscience & Therapeutics - Wiley Online Library Pharmacology of Ramelteon, a Selective MT1/MT2 Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders - Miyamoto - 2009 - CNS Neuroscience & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0c9dcc37-8d38-4e2a-bf30-a449b5342f4f/cns_066_f1.gif)
Pharmacology of Ramelteon, a Selective MT1/MT2 Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders - Miyamoto - 2009 - CNS Neuroscience & Therapeutics - Wiley Online Library
![Ramelteon in the Treatment of Delirium: New Perspectives from Reported Findings and a Case Observation | Bentham Science Ramelteon in the Treatment of Delirium: New Perspectives from Reported Findings and a Case Observation | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/cdth/14/3/001.jpg)
Ramelteon in the Treatment of Delirium: New Perspectives from Reported Findings and a Case Observation | Bentham Science
![Drug Criteria & Outcomes: Ramelteon (Rozerem) Formulary Evaluation | 2006-01-01 | AHC Media: Continuing Medical Education Publishing Drug Criteria & Outcomes: Ramelteon (Rozerem) Formulary Evaluation | 2006-01-01 | AHC Media: Continuing Medical Education Publishing](https://www.reliasmedia.com/ext/resources/images/ahc/ahcimg_26/dfr012006_table2.gif)
Drug Criteria & Outcomes: Ramelteon (Rozerem) Formulary Evaluation | 2006-01-01 | AHC Media: Continuing Medical Education Publishing
![Pharmacology of Ramelteon, a Selective MT1/MT2 Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders - Miyamoto - 2009 - CNS Neuroscience & Therapeutics - Wiley Online Library Pharmacology of Ramelteon, a Selective MT1/MT2 Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders - Miyamoto - 2009 - CNS Neuroscience & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9e2e94a6-e101-47a0-bbe3-414b35a16d46/cns_066_f12.gif)
Pharmacology of Ramelteon, a Selective MT1/MT2 Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders - Miyamoto - 2009 - CNS Neuroscience & Therapeutics - Wiley Online Library
![IJMS | Free Full-Text | Melatonin Regulates Aging and Neurodegeneration through Energy Metabolism, Epigenetics, Autophagy and Circadian Rhythm Pathways | HTML IJMS | Free Full-Text | Melatonin Regulates Aging and Neurodegeneration through Energy Metabolism, Epigenetics, Autophagy and Circadian Rhythm Pathways | HTML](https://www.mdpi.com/ijms/ijms-15-16848/article_deploy/html/images/ijms-15-16848-g001.png)